SS Innovations Names Arvind Palaniappan Interim CFO

SS Innovations, developer of surgical robotic technologies, has appointed Arvind Palaniappan as its interim chief financial officer (CFO), effective May 1.

Departing SS Innovations CFO Anup Sethi will stay available to advise the company before a permanent CFO is appointed. The company began a search to identify and recruit a permanent successor for the CFO position.

Palaniappan is a chartered accountant with the Institute of Chartered Accountant, England and Wales with more than three decades of experience in accounting and financial management, risk and controls consulting, assurance and compliance and global business outsourcing process delivery.

Since February 2020, he was principal of Trogon Consulting, a private consulting firm providing outsourced CFO and risk management services to private and public clients. From 2006 to 2020, he had a number of executive positions, including managing director for Accenture Solutions in India.

Other previous affiliations include Axis Consulting Services in Bangalore, Intel Technologies India in Bangalore, and Arthur Andersen in New Delhi.

“We are pleased to appoint Arvind as the Interim CFO of SS Innovations,” said SS Innovations chairman and CEO Dr. Sudhir Srivastava. “He is a seasoned financial and operations executive who brings us a wealth of accounting and financial management experience and expertise. We are confident in a seamless transition of responsibilities.”

Last month, the company successfully performed India’s first north-to-south robotic cardiac telesurgery, bridging a 2,000-kilometer distance between the company’s headquarters in Gurugram, New Delhi, and the Aster CMI Hospital in Bengaluru.

“On behalf of the Board of Directors and executive team, I want to thank Anup for his financial leadership and many contributions to SS Innovations over the past seven years, including most recently in the role of CFO,” said Dr. Srivastava. “He helped build strong accounting and finance functions that drove the growth of our business, supported the launch of more than 80 surgical robotic systems in India and overseas, and allowed us to transition from a high growth start up to a publicly-traded company. We mutually agreed that the milestone of the uplisting of our common stock to Nasdaq on April 25 provided an opportune time to commence the CFO transition. We are grateful that Anup has agreed to be an advisor during this transition period and wish him all the best in his next endeavors.”